Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages.
about
Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1Research gaps in defining the biological link between HIV risk and hormonal contraceptionHuman immunodeficiency virus and heparan sulfate: from attachment to entry inhibitionHIV: cell binding and entryRole of heparan sulfate in sexually transmitted infectionsRenal epithelial cells produce and spread HIV-1 via T-cell contactHeparan Sulfate Proteoglycans Mediate Attachment and Entry of Human T-Cell Leukemia Virus Type 1 Virions into CD4+ T CellsSecretory Leukocyte Protease Inhibitor Binds to Annexin II, a Cofactor for Macrophage HIV-1 InfectionHepatitis C virus NS5A anchor peptide disrupts human immunodeficiency virusSingle amino acid substitution (G42E) in the receptor binding domain of mouse mammary tumour virus envelope protein facilitates infection of non-murine cells in a transferrin receptor 1-independent mannerVirological synapses allow HIV-1 uptake and gene expression in renal tubular epithelial cellsSialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity.Regulation of CCR5 expression in human placenta: insights from a study of mother-to-child transmission of HIV in Malawi.Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells.PPARgamma and LXR signaling inhibit dendritic cell-mediated HIV-1 capture and trans-infectionPreferential chemotaxis of activated human CD4+ T cells by extracellular cyclophilin AThe C108g epitope in the V2 domain of gp120 functions as a potent neutralization target when introduced into envelope proteins derived from human immunodeficiency virus type 1 primary isolates.A whole genome association study of mother-to-child transmission of HIV in Malawi.HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue-Destructive Phenotype.Syndecan-Fc hybrid molecule as a potent in vitro microbicidal anti-HIV-1 agent.Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses.trans-Complementation rescue of cyclophilin A-deficient viruses reveals that the requirement for cyclophilin A in human immunodeficiency virus type 1 replication is independent of its isomerase activityDendritic cell-mediated viral transfer to T cells is required for human immunodeficiency virus type 1 persistence in the face of rapid cell turnoverCardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathwaysFeline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptorPathogenesis and treatment of HIV infection: the cellular, the immune system and the neuroendocrine systems perspective.Selective interaction of heparin with the variable region 3 within surface glycoprotein of laboratory-adapted feline immunodeficiency virusInhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120.Cyclophilin a plays distinct roles in human immunodeficiency virus type 1 entry and postentry events, as revealed by spinoculation.Glycosaminoglycans mediate retention of the poxvirus type I interferon binding protein at the cell surface to locally block interferon antiviral responses.Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histoculturesHuman T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells.Identification of amino acid residues important for heparan sulfate proteoglycan interaction within variable region 3 of the feline immunodeficiency virus surface glycoprotein.Characterization of monocyte maturation/differentiation that facilitates their transmigration across the blood-brain barrier and infection by HIV: implications for NeuroAIDS.Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disordersMolecular mechanisms linking high dose medroxyprogesterone with HIV-1 risk.Viral determinants of HIV-1 macrophage tropism.Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cellsThe HIV-1 envelope glycoprotein gp120 features four heparan sulfate binding domains, including the co-receptor binding site.
P2860
Q24670055-AFD25154-3640-4F45-83CB-521421644265Q27002559-974E9B4C-1488-4218-B6F4-DB797804A705Q27004059-C3762172-5B39-41B0-9D5D-EC0EEFCFEBF6Q27008983-1E617045-96F0-40F7-9AC0-B9574EE241AFQ27023959-5EECBE10-7E7F-4E42-BD6B-8A6B10F36BB9Q27313558-E8187267-0669-425F-8E31-ADBF21C2ABF4Q27472216-5FACFD0E-8BC7-40F1-B4A5-037DF80B8AE6Q27485184-BD3B0302-2D2E-4C92-B40B-7CDB122BDE76Q27485703-2103DE22-6D2F-4C52-AB3C-D4C9A64451E3Q28646994-E42931EF-1413-4F02-8847-0DE0287C7A5DQ30498853-C94ECF19-1887-4878-B46F-B7DBD3EA9CD9Q33328484-23970A18-8E48-471F-B700-9BC44E7310CDQ33532625-4D61C877-2F4A-4D7B-B838-4C49B84D6B22Q33591038-19588436-6B35-445F-8DC4-779E52049842Q33628817-F59EC244-4304-482A-AF7C-01F59D273D2FQ33757920-7DF7FB30-43E7-4C7B-BB3E-72ACCB1729E0Q33788792-AC6895CB-56F9-4ABB-99E8-4610FE0F1AD2Q33865715-EEC461CA-E690-4C7C-99CB-8878F9FF1C13Q33923363-8D903CAE-A312-4825-88ED-ACFC32A5FF7AQ33962742-25012DFB-6A68-4A41-80FB-5AE8435EDEA2Q34193846-743AD156-71EF-4C5C-B483-EF45B01BF332Q34227402-F64A41EF-DCE2-409D-9C18-3F1EBD68529CQ34331870-A2766357-647C-4289-9C36-CDB0A2A2C97FQ34349275-B06757DF-DDE1-4DA6-AA85-830FFE7C9E2DQ34393925-46D5FE97-7393-45E7-852F-A72E98191FC0Q34550397-8F091EA5-0E0E-4B40-A277-1AC774AB4380Q34650866-236C02C2-5BC5-48CE-8EE9-3EB532286D90Q34734101-E5885E17-2F4F-4C98-8FA0-4DA7D57138CEQ34983331-72E4E3D5-B579-4157-A361-6BB58C8FE4E0Q34999443-58582D22-837B-4CBF-B095-F6215D45AFDFQ35003207-6BC46A56-323C-4DF7-834C-D11E2C4C55B7Q35014689-654890F8-5849-42D1-934C-B4A673BFBBA3Q35024063-A060A063-A90D-4262-AEEC-AF1A1313F0F2Q35077801-6E8D7065-B978-4D3E-9763-13CE96059100Q35105210-349DE649-844C-4734-BACF-DCD984050E55Q35154529-1E03EA2A-459C-416A-98CA-90DCC3EAF2EBQ35208283-3C3E5909-52EF-4239-8787-0A4C58E6BE25Q35593158-1B0AF7BA-4ABF-42CD-840E-3963ECE1EEA0Q35634313-93EFA1E7-C3BD-4E32-964E-EFADEFBC002DQ35674470-6D5DFC6C-E03D-455E-B36D-0CE7F15448B6
P2860
Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Syndecans serve as attachment ...... y virus type 1 on macrophages.
@ast
Syndecans serve as attachment ...... y virus type 1 on macrophages.
@en
type
label
Syndecans serve as attachment ...... y virus type 1 on macrophages.
@ast
Syndecans serve as attachment ...... y virus type 1 on macrophages.
@en
prefLabel
Syndecans serve as attachment ...... y virus type 1 on macrophages.
@ast
Syndecans serve as attachment ...... y virus type 1 on macrophages.
@en
P2093
P2860
P1433
P1476
Syndecans serve as attachment ...... y virus type 1 on macrophages.
@en
P2093
P2860
P304
P356
10.1128/JVI.75.19.9187-9200.2001
P577
2001-10-01T00:00:00Z